Nanoform small is powerful logo Nanoform small is powerful logo
  • Contact Us
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
    Technology
    • CESS®
      STARMAP®
    • Biologics
      Formulations
    • Case studies
  • Services
    Services
    • GMP Manufacturing
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Annual General Meeting 2022
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Remuneration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO 2020
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
    • Pharmaceutical events
      Articles & videos
    • Subscribe
      Brochure
    • Contact
  • Careers
  • Contact

Articles & videos

All years
  • 2022
  • 2021
  • 2020
  • 2019
Media
  • Media
  • Videos
  • All categories
nanoform-2
October 31, 2022

Article : Inspiring a new era of patient-centric medicines

How can the industry support the development of new patient-centric medicines? Our CCO Christian Jones discusses the actions pharma companies can take to ensure patients are at the forefront in the Inspiring Science Chemistry World collection, and how our game-changing technologies can help.
Learn more
nanoform-3
October 28, 2022

Article : Small is a Powerful Ingredient for Patient Centric Formulations

Patient centricity is fast becoming a major consideration during drug discovery and development, with customer input emerging as a key input for the whole process. Discover how Nanoform is adapting to the shift toward patient-centricity in this Pharmaceutical Technology article, written by Frédérique Bordes-Picard, Vice-President of Business Development.
Learn more
October 6, 2022

Article : Small is Powerful: A Globally Unique Capability for Nanoforming HPAPI’s

In oncology and the wider pharmaceutical market, there is a surge in demand for high- potency active pharmaceutical ingredients (HPAPIs). Dr. David Rowe, Head of Manufacturing and Antonio da Silva, Senior Director Business Operations discuss the globally unique capabilities that Nanoform possess.

Learn more
nanoform-3
August 17, 2022

Podcast : Empowering a New Era of Patient-Centric Medicines With Nanoform Technologies

Christian Jones Chief Commercial Officer at Nanoform discusses what it truly means to be patient-centric in the modern pharmaceutical industry. Discover the challenges pharma companies are facing as they switch focus, as well as the actions and technologies companies are implementing to help achieve a brighter future for patients.

Learn more
July 11, 2022

Article : Embracing GMP Manufacturing to Meet Pharma’s Future

The pharma industry is looking to novel technologies for answers to its challenges in all areas of drug development. Such technologies must be able to adhere to GMP for both clinical and commercial manufacturing. Read this article with DCAT Value Chain Insights to discover how Nanoform can increase your chances of success.

Learn more
nanoform-7
May 16, 2022

Article: Nanoparticle engineering, Streamlining Drug Development with AI

Elisabetta Micelotta, Science & Technology Team Leader and Jamie Unwin, Commercial Insights Officer discuss the value in applying AI in Pharma and how this can be leveraged to create new and better drugs available faster than would be possible otherwise.

Learn more
nanoform-8
April 9, 2022

Article: Nanotechnology : A next-generation tool for pulmonary and nasal delivery

Frédérique Bordes-Picard, Vice-President of Business Development looks at the role of nanotechnology is nasal and pulmonary routes of drug delivery and explains how nanoparticle solutions could transform patient comfort and compliance.

Learn more
April 7, 2022

Poster: from Nanoformed Powder to 3D printable ink

The flexibility of 3D printing can enable more personalized pharmaceutical products than traditional manufacturing. We embarked on a study to assess the stability of nanoformed piroxicam in 3D printable ink and whether dose control could be achieved. Explore the journey of our piroxicam nanoparticles from nanoformed powder to 3D printable ink in this poster.

Learn more
December 17, 2021

11th Annual PODD Recap 2021 Newsletter – Q&A with Edward Hæggström

Our CEO, Prof. Edward Hæggström was featured in the PODD 2021 newsletter where he discussed the exciting developments at Nanoform and the market trends driving the innovation. Edward also delved into the collaborations and partnerships adding value to Nanoform’s nanoparticle engineering technologies.

Learn more
November 11, 2021

Nanoparticle Engineering for Patient-Centric Drug Formulation

In the final edition of PMPS in 2021, Barry Derham, Senior Formulation Scientist, delved into how nanotechnology is a way that drug manufacturers are advancing their formulations to suit ever-changing patient needs.
Learn more
November 11, 2021

Nanoparticle Engineering And 3DP Delivery For Game-Changing Oral Therapeutics

In the July 2021 issue of ONDrugDelivery, Niklas Sandler and Thomas West consider the technological advances in nanoparticle engineering that can improve the bioavailability and delivery of oral therapeutics.

Learn more
nanoform-quotient-sciences-image
May 18, 2021

Positive results from first-in-human trial of nanoformed piroxicam

Overcoming Drug Development Challenges with Nanotechnology: Piroxicam, a commercially available non-steroidal anti-inflammatory drug, was nanoformed as a model compound to demonstrate the potential benefits of our CESS(R) nanoforming technology for improving solubility, dissolution and in vivo absorption.

Learn more
nanoform-bio-europe-spring-featured
March 30, 2021

Video: Bio-Europe panel discussion

Our Head of AI, Prof. Jukka Corander joined a panel discussion at BIO-Europe Spring 2021 on “Big data & AI: applications in the real world”. Watch the video to find out out how Sparse Data AI & specifically STARMAP® can transform healthcare.

Learn more
November 20, 2020

Nanoparticle Engineering: Revolutionising Oral Drug Delivery ‘White Paper’

Our CTO Niklas Sandler, and Pharmaceutical Development Manager Satu Lakio explain how our nanoparticle engineering technology is revolutionizing oral drug delivery by enhancing solubility and bioavailability.

Learn more
November 18, 2020

Avanza Börsdag

Our CEO Edward Hæggström, CFO Albert Hæggström, and CCO Christian Jones present an overview of our nanoforming platform technology at Avanza Börsdag.

Learn more
October 20, 2020

Recording of conference call in conjunction with press release

A record of the conference call held to discuss Nanoform’s initiation of the first human trial of a drug candidate nanoformed using our proprietary CESS® technology.

Learn more
August 18, 2020

PharmTech

Nanoform scientists outline how our innovative CESS® technology can help overcome the obstacles many drug candidates face when trying to make it through clinical trials.

Learn more
July 31, 2020

ONdrugDelivery

Our CTO, Niklas Sandler, and Pharmaceutical Development Manager, Satu Lakio, discuss the advantages of our nanoparticle engineering technology in oral drug development and delivery by boosting solubility and bioavailability.

Learn more
July 1, 2020

Business Trends

Our CCO, Christian Jones, discusses the launch our US subsidiary and the extension our partnership with Orion Corporation with Business Trends Magazine.

Learn more
April 20, 2020

CHEManager

Nanoform CEO Edward Haeggström and CFO Albert Haeggström discussed the benefits of our cutting-edge nanoforming technology for improving efficiency in Pharma and increasing the rate of drug approval for market with CHEManager.

Learn more
March 30, 2020

Nanoform Brochure

In this brochure we share our story, explaining how our unique nanoforming services, including our game-changing CESS® technology, can provide solutions to drug development challenges in Pharma.

Learn more
March 16, 2020

Chemicals Knowledge Hub

Our CBO, Dr. Gonçalo Rebelo de Andrade, discusses with Chemicals Knowledge Hub magazine how our nanoforming technology can improve efficiency in the pharmaceutical industry by creating new avenues for drug delivery.

Learn more
March 2, 2020

The Small Molecule Manufacturer

Our CCO, Christian Jones, shared his insights with The Medicine Maker into how our nanoforming technology can improve efficiency and create new opportunities for drug development.

Learn more
November 18, 2019

Chemistry World

Our CTO, Niklas Sandler, examines the importance of technological innovation for treating age-related diseases in Chemistry World’s Future of Pharma digital supplement.

Learn more
July 22, 2019

Chemistry World

Our scientists discuss the advantages of applying a multidisciplinary approach to Pharma innovation in the Chemistry World – Voices in Chemistry digital supplement.

Learn more
July 12, 2019

Cleanroom Technology

Our CTO, Niklas Sandler, discusses the growing demand for nanoformed drug particles and the advantages of our proprietary nanoforming technology offers with Cleanroom Technology Magazine.

Learn more
June 7, 2019

Technology Networks

Our Head of AI, Jukka Corrander, spoke to Technology Networks about our innovative use of sparse data AI with our proprietary STARMAP™ technology.

Learn more
June 1, 2019

BioPharm International

Our CBO, Gonçalo Rebelo de Andrade, discusses the advantages offered by our excipient-free nanoforming technology with BioPharm International.

Learn more
May 29, 2019

European Pharmaceutical Manufacturer

Our CTO, Niklas Sandler, explains how our innovative use of nanoforming technology and sparse-data AI is being used to enhance drug molecules in the European Pharmaceutical Manufacturer.

Learn more

Contact us

+358 29 370 0150
info@nanoform.com

  • Privacy notice
  • Cookies

Subscribe

Read more about our protection of your personal data.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Company number: 2730572-8